Società Merck & Co., Inc. London S.E.

0QAH

US58933Y1055

Prodotti farmaceutici

Consensus Analisti

Attività

Vendite per attività

Vendite per regione

Dirigenti

Amministratori

Classe di azioni

Azionisti

Partecipazioni

Coordinate società

Società del gruppo

Settore

Vendite per attività

Vendite per regione

Rating per Merck & Co., Inc.

Revisioni EPS

Utili trimestrali - Indice di sorpresa

Settore Prodotti farmaceutici - Altri

Tempo reale stimato Tradegate Altri mercati azionari 17:35:05 17/06/2024			Variaz. 5gg	Var. 1 gen.
119,5 ^EUR	0,00%		+2,60%	0,00%

13/06	Gli operatori sanitari ad alto rischio possono ricevere il vaccino contro l'ebola di routine, dice Gavi	RE
13/06	AbbVie conclude un accordo di licenza per un farmaco contro i disturbi immunitari con la cinese FutureGen	RE

Merck & Co. Inc. è specializzata nello sviluppo, nella produzione e nella commercializzazione di prodotti terapeutici e vaccini venduti dietro prescrizione medica. Le vendite nette sono così suddivise per attività:
- vendita di prodotti farmaceutici (69,7%): per il trattamento di ipertensione, osteoporosi, aterosclerosi, malattie respiratorie, batteriche e fungine, oftalmologiche e urologiche, emicrania acuta, perdita di capelli negli uomini, ecc;
- vendita di vaccini (18%);
- vendita di prodotti per la salute degli animali (9,4%);
- altro (2,9%).
Le vendite nette sono distribuite geograficamente come segue: Stati Uniti (45,9%), Europa/Medio Oriente/Africa (24,5%), Cina (8,8%), Giappone (6,1%), Asia/Pacifico (6,1%), America Latina (4,3%) e altro (4,3%).

USD in Milioni	2022	Peso	2023	Peso	Delta
Pharmaceutical 89,1 %	52 005	87,7 %	53 583	89,1 %	+3,03%
Animal Health 9,4 %	5 550	9,4 %	5 625	9,4 %	+1,35%
Other 1,5 %	1 728	2,9 %	907	1,5 %	-47,51%

USD in Milioni	2022	Peso	2023	Peso	Delta
United States 47,4 %	27 206	45,9 %	28 480	47,4 %	+4,68%
Europe, Middle East and Africa 22,0 %	14 493	24,4 %	13 254	22,0 %	-8,55%
China 11,3 %	5 191	8,8 %	6 802	11,3 %	+31,03%
Asia Pacific 5,4 %	3 614	6,1 %	3 225	5,4 %	-10,76%
Japan 5,3 %	3 629	6,1 %	3 164	5,3 %	-12,81%
Latin America 5,1 %	2 582	4,4 %	3 086	5,1 %	+19,52%
Other 3,5 %	2 568	4,3 %	2 104	3,5 %	-18,07%

Dirigenti	Titolo	Età	Da
Robert Davis CEO	Chief Executive Officer	57	01/04/14
Caroline Litchfield DFI	Director of Finance/CFO	55	01/01/90
Dave Williams CTO	Chief Tech/Sci/R&D Officer	55	01/08/20
Joseph Romanelli IRC	Investor Relations Contact	50	01/01/96
Peter Dannenbaum IRC	Investor Relations Contact	-	01/07/17
Andre Musto PRN	Corporate Officer/Principal	-	01/07/14
Brooke Hinkson PRN	Corporate Officer/Principal	-	01/08/15
Carol Bowden PRN	Corporate Officer/Principal	-	01/04/14
Dalton Smart AUD	Comptroller/Controller/Auditor	58	01/11/09
James Matteucci PRN	Corporate Officer/Principal	-	01/01/03

Amministratori	Titolo	Età	Da
Tom Glocer BRD	Director/Board Member	63	27/11/07
Pamela Craig BRD	Director/Board Member	67	01/09/15
Inge Thulin BRD	Director/Board Member	69	01/03/18
Patricia Russo BRD	Director/Board Member	71	01/09/95
Risa Lavizzo-Mourey BRD	Director/Board Member	69	26/05/20
Robert Davis CEO	Chief Executive Officer	57	01/04/14
Douglas Baker BRD	Director/Board Member	65	24/05/22
Stephen Mayo BRD	Director/Board Member	62	15/03/21
Kathy Warden BRD	Director/Board Member	52	16/03/20
Christine Seidman BRD	Director/Board Member	71	16/03/20

	Voto	Quantità	Flottante	Autocontrollo	Flottante totale
Azione A	1	3 577 208 962	2 531 418 332 ( 70,77 %)	1 044 402 655 ( 29,20 %)	70,77 %

Nome	Azioni	%	Valorizzazione
Vanguard Fiduciary Trust Co. 9,605 %	243 269 899	9,605 %	30 540 M €
BlackRock Advisors LLC 6,177 %	156 460 386	6,177 %	19 642 M €
STATE STREET CORPORATION 4,636 %	117 425 530	4,636 %	14 742 M €
Wellington Management Co. LLP 3,409 %	86 348 259	3,409 %	10 840 M €
Geode Capital Management LLC 2,227 %	56 411 229	2,227 %	7 082 M €
Fidelity Management & Research Co. LLC 2,058 %	52 116 893	2,058 %	6 543 M €
BlackRock Life Ltd. 1,703 %	43 121 867	1,703 %	5 414 M €
Eaton Vance Management 1,639 %	41 505 855	1,639 %	5 211 M €
Merrill Lynch International 1,484 %	37 576 885	1,484 %	4 717 M €
T. Rowe Price International Ltd. 1,170 %	29 639 517	1,170 %	3 721 M €

Nome	Azioni	%	Valorizzazione
Caixa DTVM SA 0,001503 %	304 520	0,001503 %	5 M €
BB Gestão de Recursos DTVM SA 0,000900 %	182 400	0,000900 %	3 M €
Safra Asset Management Ltda. 0,000318 %	64 500	0,000318 %	1 M €
Bram Bradesco Asset Management S/A DTVM 0,000205 %	41 594	0,000205 %	651 626 €
XP Allocation Asset Management Ltda. 0,000093 %	18 763	0,000093 %	293 948 €

Nome	Azioni	%	Valorizzazione
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. 10.32%	13 443 693	10.32%	295 909 530 $
ENTRADA THERAPEUTICS, INC. 5.15%	1 739 768	5.15%	26 914 211 $
XILIO THERAPEUTICS, INC. 4.02%	1 483 414	4.02%	1 602 087 $
EVAXION BIOTECH A/S 12.13%	2 297 884	12.13%	843 323 $

Merck & Co., Inc.

126 East Lincoln Avenue

07065, Rahway

+908 740 4000

http://www.merck.com

Nome	Categoria e settore
MSD Regional Business Support Center GmbH MSD Regional Business Support Center GmbH Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., MSD Regional Business Support Center GmbH is a German company that provides management consulting services. The company is based in Munich, Germany. Jutta König has been the CEO of the company since 2021.	Miscellaneous Commercial Services
Merck Holdings, Inc.
MSD International GmbH (Switzerland) MSD International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD International GmbH (Switzerland) is a Swiss company that discovers, develops and markets human and animal health products. The company is located in Switzerland.	Pharmaceuticals: Major
Schering Plough International Finance Co. BV
MSD Human Health Holding BV MSD Human Health Holding BV Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD Human Health Holding BV discovers, develops and markets human and animal health products. The company is based in Oss, Netherlands.	Pharmaceuticals: Major
Merck Sharp & Dohme LLC Merck Sharp & Dohme LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Sharp & Dohme LLC is a pharmaceutical company. The company is based in Kenilworth, NJ.	Pharmaceuticals: Major
Merck Sharp & Dohme Corp. Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.	Pharmaceuticals: Major
Essex Chemie AG
Merck Sharp & Dohme BV Merck Sharp & Dohme BV Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Sharp & Dohme BV is a Dutch company that manufactures and distributes pharmaceutical products. The company is based in Haarlem, the Netherlands.	Pharmaceuticals: Major
MSD Finance 2 LLC
MSD Animal Health Pension Scheme MSD Animal Health Pension Scheme Investment ManagersFinance Part of Merck & Co., Inc., MSD Animal Health Pension Scheme is a British company. The company is located in the UK.	Investment Managers
Organon (India) Pvt Ltd. Organon (India) Pvt Ltd. Pharmaceuticals: MajorHealth Technology Organon India Pvt Ltd. manufactures and distribution of pharmaceutical preparations. The company is headquartered in Mumbai, India.	Pharmaceuticals: Major
Dashtag Dashtag Financial ConglomeratesFinance Founded in 1906, Dashtag is a part of Organon & Co. and operates an investment holding British company. The company is based in Hoddesdon, UK.	Financial Conglomerates
Merck Sharp & Dohme Manufacturing Unlimited Co.
Merck International Holdings LLC
MSD Sharp & Dohme GmbH MSD Sharp & Dohme GmbH Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD Sharp & Dohme GmbH develops and manufactures pharmaceutical products. The company is based in Haar, Germany. The German company was founded in 1891. Chantal Friebertshäuser has been the CEO of the company since 2007.	Pharmaceuticals: Major
Organon LLC
Intervet India Pvt Ltd.
MSD International Business GmbH
GTS FI BV GTS FI BV Financial ConglomeratesFinance Part of Organon & Co., GTS FI BV is an investment holding Dutch company that provides financing services. The company is located in Netherlands.	Financial Conglomerates
MSD FI BV MSD FI BV Financial ConglomeratesFinance Part of Merck & Co., Inc., MSD FI BV is an investment holding Dutch company. The company is based in Haarlem, Netherlands.	Financial Conglomerates
MSD Pharmaceuticals Pvt Ltd.
MSD Pharmaceuticals Investments 3 (Bermuda) MSD Pharmaceuticals Investments 3 (Bermuda) Financial ConglomeratesFinance Part of Merck & Co., Inc., MSD Pharmaceuticals Investments 3 (Bermuda) provides investment services. The company is located in Bermuda.	Financial Conglomerates
Merck Sharp & Dohme Finance Europe Ltd. Merck Sharp & Dohme Finance Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1993, Merck Sharp & Dohme Finance Europe Ltd. is a British company that provides business support services. Part of Merck & Co., Inc., the company is based in Hoddesdon, UK.	Miscellaneous Commercial Services
FULFORD (INDIA) LIMITED	Pharmaceuticals: Major

Rating Trading

Rating Investimento

ESG Refinitiv

Altri rating

Vendita

Buy

Raccomandazione media

Buy

Numero di analisti

Ultimo prezzo di chiusura

129,5 USD

Prezzo obiettivo medio

142,7 USD

Differenza / Target Medio

+10,20%

Consenso

Revisioni delle Stime

Calendario della società

Biotecnologia/Farmaceutici

Biotecnologia/Farmaceutici

Prodotti farmaceutici

Prodotti farmaceutici - Altri

	Variaz. 1 gen.	Capi.
ELI LILLY AND COMPANY	+51,45%	791 Mrd
NOVO NORDISK A/S	+40,45%	630 Mrd
ABBVIE INC.	+9,30%	298 Mrd
ASTRAZENECA PLC	+17,38%	246 Mrd
ROCHE HOLDING AG	+0,65%	225 Mrd
NOVARTIS AG	+10,26%	218 Mrd
AMGEN INC.	+4,67%	160 Mrd
PFIZER, INC.	-5,64%	156 Mrd
SANOFI	-2,33%	116 Mrd

Prodotti farmaceutici - Altri